(1) Marquardt, W.C., Demaree, R.S. and Grieve, R.B.( 2000). Parasitology and vector biology. 2nd edition.Academic Press, USA, 702p.
(2) Neouimine, N.I. (1996). Leishmaniasis in the Eastern Mediterranean region. East Mediterranean Health J. V. 1, P. 94-101.
(3) Magill, A.J. (1995). Epidemiology of the leishmaniasis. Dermatol. Clin. V. 3 (3), P. 505-523.
(4) Fernandez-Guerrero, M.L., Robles, P., Rivas, P., Mojer, F., Muniz, G. and Gorgolas, M. (2004).Visceral leishmaniasis in immuno-compromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta. Trop. V. 90 (1), P. 11-16.
(5) Walker, M., Kublin, J.C. and Zunt, J.R. (2006). Parasitic central nervous system infections in immunocomprised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin. Infect. Dis. V. 42(1), P. 115-125.
(6) Korzeniewski, K. and Olszanski, R.( 2004). Leishmaniasis among soldiers of stabilization forces in Iraq. Review article. Int. Marit. Health. V. 55 (1-4), P. 155-163.
(7) Choi, C.M. and Lerner, E.A. (2001). Leishmaniasis as an emerging infection. J. Investig, Dermatol. Symp. Proc. V. 6(3) P.175-182.
(8) Bucheton, B., El-Safi, S.H., Hammad, A., Kheir, M.M., Eudes, N., Dessein, A.J. and Mary, C. (2003). Antileishmanial antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody responses occur in resistant subjects and are not predictive of disease. Trans. Roy. Soc. Trop. Med. Hyg. V. 97(4), P. 463-468.
(9) Mayrink, W., Araujo, F.G. and Magalhaes, P.A. (1967). Fluorescent antibody test in visceral leishmanaiasis. 1- Sensitivity of the test. Rev. Inst. Med. Trop. Sao Paulo. V. 9(3) P.172-174.
(10) Duxbury, R.E. and Sadun, E.H. (1964). Fluorescent antibody technique for the sero-diagnosis of visceral leishmaniasis. Am. J. Trop. Med. Hyg. V. 13, P. 525-529.
(11) Al-Samarai, A.M. and Al-Obaidi, H.S. (2009). Cutaneous leishmaniasis in Iraq. J. Infect. Developing Countries. V. 3(2), P. 123-129.
(12) Aronson, N.E., Sanders, J.W. and Moran, K.A. (2006). In harm’s way: Infections in deployed American military forces. Clin. Infect. Dis. V. 43(8), P. 1045-1051.